2014
DOI: 10.1038/nbt.2960
|View full text |Cite
|
Sign up to set email alerts
|

Overcoming immunological barriers in regenerative medicine

Abstract: Regenerative therapies that use allogeneic cells are likely to encounter immunological barriers similar to those that occur with transplantation of solid organs and allogeneic hematopoietic stem cells (HSCs). Decades of experience in clinical transplantation hold valuable lessons for regenerative medicine, offering approaches for developing tolerance-induction treatments relevant to cell therapies. Outside the field of solid-organ and allogeneic HSC transplantation, new strategies are emerging for controlling … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
97
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 118 publications
(100 citation statements)
references
References 122 publications
(101 reference statements)
0
97
0
Order By: Relevance
“…Mesenchymal stromal cells (MSC) are widely used for tissue engineering applications because of their capacity to promote tissue regeneration (Zakrzewski et al 2014) while modulating immune responses (Prockop and Oh 2012). Currently, there are more than 300 registered clinical trials (www.clinicaltrials.gov) in which MSC are used to treat several different diseases, with applications ranging from bone and cartilage repair to spinal cord, cardiac, and bladder regeneration (Kramer et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Mesenchymal stromal cells (MSC) are widely used for tissue engineering applications because of their capacity to promote tissue regeneration (Zakrzewski et al 2014) while modulating immune responses (Prockop and Oh 2012). Currently, there are more than 300 registered clinical trials (www.clinicaltrials.gov) in which MSC are used to treat several different diseases, with applications ranging from bone and cartilage repair to spinal cord, cardiac, and bladder regeneration (Kramer et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…[16][17][18][19] Understanding the direct immunosuppressive effect of nanoparticles and resultant development of new immunosuppressive therapies can impact both pharmaceutical and regenerative medicine technologies. 9,20,21 When developing methods to suppress immune response, it is important to consider both innate and adaptive immune responses. Innate immunity involves the first response activation of macrophages and neutrophils that secrete specific cytokines, which produce local inflammation at the site of reaction.…”
Section: Introductionmentioning
confidence: 99%
“…Some of them are closer to clinical testing than others, but all represent promising advances in the field of transplantation tolerance. More information on these and other approaches can be found in several recent reviews [2,3].…”
Section: State Of the Fieldmentioning
confidence: 99%